Glycomics/Glycobiology Market is expected to reach 2.1 billion USD by 2025

Tuesday, May 23, 2017 Women Health News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, May 22, 2017 /PRNewswire/ --

Highlights

·         The global glycomics/glycobiology market is

expected to reach USD 2.1 billion by 2025, according to a new report by Grand View Research, Inc.

·         Increasing investment in R&D by research institutes and pharmaceutical & biotechnology companies has been a major factor

driving market growth.

·         Escalating popularity of personalized medicines for the treatment of several severe chronic diseases and genetic disorders is another major factor contributing toward the growth.

·         Glycans play a crucial role in modulating various biological processes and their assessment can help determine the susceptibility to diseases & response to treatment.

·         Enzymes segment is the fastest growing segment of the glycobiology market in 2016, due to its huge application in research & diagnostics and repetitive purchase of these products

·         The academic and research institutes dominated in terms of revenue in 2016, owing to the large focus on glycobiology research and proteomics study

The global glycomics/glycobiology market is expected to reach USD 2.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing investment in R&D by research institutes and pharmaceutical & biotechnology companies has been a major factor driving market growth. In addition, technological advancement has led to increased demand for advanced glycomics products for drug discovery & development, diagnostics, and oncology research.

Escalating popularity of personalized medicines for the treatment of several severe chronic diseases and genetic disorders is another major factor contributing toward the growth. Personalized medicines involve the application of glycomics for the study of structure and function of glycans that are attached to biomolecules. Glycans play a crucial role in modulating various biological processes and their assessment can help determine the susceptibility to diseases & response to treatment. Thus, application of glycobiology products is expected to rise in near future, owing to their high potential in personalized medicine. Untapped opportunities in developing regions, including Asia Pacific and Africa, are another major factor supporting the growth of the glycomics market. Glycomics research is important for comprehensive study of glycomes to understand the cellular signaling pathways, cell functions, genetic structure, and physiological & pathological aspects. Glycomics research has become more popular these days due to its advantages over genomic/proteomic analysis that cannot be used to study many pathological processes. Thus, the demand for advanced glycomics products by researchers and healthcare professionals is expected to fuel the sector growth. Further Key Findings From the Report Suggest: Enzymes segment is the fastest growing segment of the glycobiology market in 2016, due to its huge application in research & diagnostics and repetitive purchase of these products In the application segment, drug discovery & development accounted for the largest revenue share in 2016, owing to the growing focus on novel drug development and demand for personalized medicines The academic and research institutes dominated in terms of revenue in 2016, owing to the large focus on glycobiology research and proteomics study The North America glycobiology market is the leading regional sector and expected to dominate the market during forecast period Existence of large number of research laboratories, pharmaceutical companies, and biotechnology companies in North America region is the major reason for the high demand for glycobiology products in this region The Asia Pacific glycobiology market is expected to grow at the highest growth rate during the forecast period Read the full report: http://www.reportlinker.com/p04899226/Glycomics-Glycobiology-Market-Analysis-By-Product-Enzymes-Kits-Reagents-Instruments-By-Application-Drug-Discovery-Development-Diagnostics-By-End-use-And-Segment-Forecasts.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com

__________________________Contact Clare: [email protected]US: (339)-368-6001Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/glycomicsglycobiology-market-is-expected-to-reach-21-billion-usd-by-2025-300461940.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store